What a decade of inspection reports shows about firm tasked with helping make vaccine
What a decade of inspection reports shows about firm tasked with helping make vaccine Johnson & Johnson manufacturer’s embattled history with the FDA Replay Video UP NEXT Even as shots of the Johnson & Johnson COVID-19 vaccine resume across the country following a recent federally-recommended pause, new manufacturing at a key facility tasked with helping make the vaccine is still on hold. Emergent BioSolutions -- the company whose Baltimore-area plant had been developing a key component for both Johnson & Johnson and AstraZeneca -- accidentally cross-contaminated and ruined up to 15 milli...